Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bunce

Showing results (181-190 of 209) with videos related to

Pageof 21
Sort By:
Leukemia|July 24, 2015
Metabolic plasticity in CLL: adaptation to the hypoxic nicheK M Koczula, C Ludwig, R Hayden, et al.
British Journal of Cancer|October 23, 2021
Valproic acid disables the Nrf2 anti-oxidant response in acute myeloid leukaemia cells enhancing reactive oxygen species-mediated killingYao Jiang, Andrew D Southam, Sandro Trova, et al.
British Journal of Cancer|September 11, 2003
Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentationH P Marsh, N A Haldar, M Bunce, et al.
Tissue Antigens|April 1, 1994
HLA-B15: a widespread and diverse family of HLA-B allelesW H Hildebrand, J D Domena, S Y Shen, et al.
Blood Cancer Journal|July 26, 2012
Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain productionF L Khanim, B A M E Merrick, H V Giles, et al.
Cancer Research|May 7, 2015
Drug Redeployment to Kill Leukemia and Lymphoma Cells by Disrupting SCD1-Mediated Synthesis of Monounsaturated Fatty AcidsAndrew D Southam, Farhat L Khanim, Rachel E Hayden, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2009
The evolutionary history of the extinct ratite moa and New Zealand Neogene paleogeographyM Bunce, T H Worthy, M J Phillips, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2000
The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infectionK J Jeffery, A A Siddiqui, M Bunce, et al.
Cancer Research|January 25, 2003
The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugsJulian C Desmond, Joanne C Mountford, Mark T Drayson, et al.
Chemistry & Biology|December 23, 2008
Supramolecular iron cylinder with unprecedented DNA binding is a potent cytostatic and apoptotic agent without exhibiting genotoxicityAnna C G Hotze, Nikolas J Hodges, Rachel E Hayden, et al.
Pageof 21

Showing results (181-190 of 209) with videos related to

Sort By:
Pageof 21
Leukemia|July 24, 2015
Metabolic plasticity in CLL: adaptation to the hypoxic nicheK M Koczula, C Ludwig, R Hayden, et al.
British Journal of Cancer|October 23, 2021
Valproic acid disables the Nrf2 anti-oxidant response in acute myeloid leukaemia cells enhancing reactive oxygen species-mediated killingYao Jiang, Andrew D Southam, Sandro Trova, et al.
British Journal of Cancer|September 11, 2003
Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentationH P Marsh, N A Haldar, M Bunce, et al.
Tissue Antigens|April 1, 1994
HLA-B15: a widespread and diverse family of HLA-B allelesW H Hildebrand, J D Domena, S Y Shen, et al.
Blood Cancer Journal|July 26, 2012
Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain productionF L Khanim, B A M E Merrick, H V Giles, et al.
Cancer Research|May 7, 2015
Drug Redeployment to Kill Leukemia and Lymphoma Cells by Disrupting SCD1-Mediated Synthesis of Monounsaturated Fatty AcidsAndrew D Southam, Farhat L Khanim, Rachel E Hayden, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2009
The evolutionary history of the extinct ratite moa and New Zealand Neogene paleogeographyM Bunce, T H Worthy, M J Phillips, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2000
The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infectionK J Jeffery, A A Siddiqui, M Bunce, et al.
Cancer Research|January 25, 2003
The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugsJulian C Desmond, Joanne C Mountford, Mark T Drayson, et al.
Chemistry & Biology|December 23, 2008
Supramolecular iron cylinder with unprecedented DNA binding is a potent cytostatic and apoptotic agent without exhibiting genotoxicityAnna C G Hotze, Nikolas J Hodges, Rachel E Hayden, et al.
Pageof 21